Dataset Information


Loss of Muscle Carnitine Palmitoyltransferase 2 Prevents Diet-Induced Obesity and Insulin Resistance despite Long-Chain Acylcarnitine Accumulation.

ABSTRACT: To assess the effects of acylcarnitine accumulation on muscle insulin sensitivity, a model of muscle acylcarnitine accumulation was generated by deleting carnitine palmitoyltransferase 2 (CPT2) specifically from skeletal muscle (Cpt2Sk-/- mice). CPT2 is an irreplaceable enzyme for mitochondrial long-chain fatty acid oxidation, converting matrix acylcarnitines to acyl-CoAs. Compared with controls, Cpt2Sk-/- muscles do not accumulate anabolic lipids but do accumulate ?22-fold more long-chain acylcarnitines. High-fat-fed Cpt2Sk-/- mice resist weight gain, adiposity, glucose intolerance, insulin resistance, and impairments in insulin-induced Akt phosphorylation. Obesity resistance of Cpt2Sk-/- mice could be attributed to increases in lipid excretion via feces, GFD15 production, and energy expenditure. L-carnitine supplement intervention lowers acylcarnitines and improves insulin sensitivity independent of muscle mitochondrial fatty acid oxidative capacity. The loss of muscle CPT2 results in a high degree of long-chain acylcarnitine accumulation, simultaneously protecting against diet-induced obesity and insulin resistance.


PROVIDER: S-EPMC7680579 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC4285541 | BioStudies
2006-01-01 | S-EPMC2557099 | BioStudies
1000-01-01 | S-EPMC2714383 | BioStudies
2017-01-01 | S-EPMC5701125 | BioStudies
2017-01-01 | S-EPMC5614545 | BioStudies
2018-01-01 | S-EPMC6057484 | BioStudies
2019-01-01 | S-EPMC6650415 | BioStudies
2018-01-01 | S-EPMC6039238 | BioStudies
2014-01-01 | S-EPMC4080147 | BioStudies
2017-01-01 | S-EPMC5209287 | BioStudies